Rosemont Drug Patent Portfolio
Rosemont owns 5 orange book drugs protected by 10 US patents with Atmeksi having the least patent protection, holding only 1 patent. And Fibricor with maximum patent protection, holding 4 patents. Given below is the list of Rosemont's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12390439 | Oral Liquid Formulation Of Methocarbamol | 09 Oct, 2044 | Active |
| US11103452 | Tramadol hydrochloride solution | 01 Sep, 2040 | Active |
| US11752103 | Tramadol hydrochloride solution | 01 Sep, 2040 | Active |
| US12343338 | Ramipril Solution For Oral Dosage | 16 Aug, 2039 | Active |
| US8623409 | Clonidine formulation | 08 Sep, 2031 | Active |
| US7569612 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7741373 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7741374 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US7915247 | Methods of use of fenofibric acid | 20 Aug, 2027 | Active |
| US8337890 | Modified release formulations containing drug-ion exchange resin complexes | 17 Apr, 2027 | Active |
Latest Legal Activities on Rosemont's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Rosemont.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent eCertificate of Correction | 28 Oct, 2025 | US12343338 |
| Mail Patent eCofC Notification | 28 Oct, 2025 | US12343338 |
| Patent eCofC Notification | 28 Oct, 2025 | US12343338 |
| Email Notification | 28 Oct, 2025 | US12343338 |
| Post Issue Communication - Certificate of Correction | 07 Oct, 2025 | US12343338 |
| Recordation of Patent Grant Mailed | 26 Aug, 2025 | US12390439 |
| Patent eGrant Notification | 19 Aug, 2025 | US12390439 |
| Mail Patent eGrant Notification | 19 Aug, 2025 | US12390439 |
| Email Notification | 19 Aug, 2025 | US12390439 |
| Recordation of Patent eGrant | 19 Aug, 2025 | US12390439 |
| Patent Issue Date Used in PTA Calculation | 19 Aug, 2025 | US12390439 |
| Email Notification | 07 Aug, 2025 | US12390439 |
| Issue Notification Mailed | 06 Aug, 2025 | US12390439 |
| Application Is Considered Ready for Issue | 25 Jul, 2025 | US12390439 |
| Dispatch to FDC | 25 Jul, 2025 | US12390439 |
Rosemont's Family Patents
Rosemont Drug List
Given below is the complete list of Rosemont's drugs and the patents protecting them.
1. Atmeksi
Atmeksi is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12390439 | Oral Liquid Formulation Of Methocarbamol |
09 Oct, 2044
(18 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atmeksi's drug page
2. Fibricor
Fibricor is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7569612 | Methods of use of fenofibric acid |
20 Aug, 2027
(1 year, 3 months from now)
| Active |
| US7741373 | Methods of use of fenofibric acid |
20 Aug, 2027
(1 year, 3 months from now)
| Active |
| US7741374 | Methods of use of fenofibric acid |
20 Aug, 2027
(1 year, 3 months from now)
| Active |
| US7915247 | Methods of use of fenofibric acid |
20 Aug, 2027
(1 year, 3 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fibricor's drug page
3. Nexiclon Xr
Nexiclon Xr is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8623409 | Clonidine formulation |
08 Sep, 2031
(5 years from now)
| Active |
| US8337890 | Modified release formulations containing drug-ion exchange resin complexes |
17 Apr, 2027
(11 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nexiclon Xr's drug page
4. Qdolo
Qdolo is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103452 | Tramadol hydrochloride solution |
01 Sep, 2040
(14 years from now)
| Active |
| US11752103 | Tramadol hydrochloride solution |
01 Sep, 2040
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qdolo's drug page
5. Vostally
Vostally is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12343338 | Ramipril Solution For Oral Dosage |
16 Aug, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vostally's drug page